Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anita Scribner"'
Autor:
Samir K, Gupta, Mezgebe, Berhe, Gordon, Crofoot, Paul, Benson, Moti, Ramgopal, James, Sims, Cheryl, McDonald, Peter, Ruane, William E, Sanchez, Anita, Scribner, Shan-Yu, Liu, Laurie A, VanderVeen, Hadas, Dvory-Sobol, Martin S, Rhee, Jared M, Baeten, Ellen, Koenig
Publikováno v:
The Lancet HIV. 10:e15-e23
Antiretroviral agents with novel mechanisms and dosing intervals could expand treatment options for people with HIV. Lenacapavir, an inhibitor of capsid protein that makes use of a unique mechanism, can be administered orally or subcutaneously. We so
Autor:
Thomas W. Johnston, David Craig, Judith Kirstein, Anita Scribner, William Simon, Jayne E. Ellis
Publikováno v:
Cardiology and Therapy
Introduction Fibrin degradation product d-dimer can be a valuable indicator for venous thromboembolism (VTE). The use of d-dimer testing in primary care settings can be limited by restricted access to laboratory services. This performance evaluation
Autor:
Jianfeng Xu, Anita Scribner, Brian A. Johns, Mark Johnson, Jerry Jeffrey, Viviana Wilches, Moti Ramgopal, Edwin DeJesus, Franco Felizarta, Christine L. Talarico, Jianjun Gan, Paul M. Benson, Roxanne C. Jewell, Etienne Dumont, Fiona Halliday, Sara Duckworth Harward
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71(5)
Background GSK2838232 is a second-generation, potent, small-molecule, oral human immunodeficiency virus type 1 (HIV-1) maturation inhibitor for once-daily administration boosted with a pharmacoenhancer. Methods The phase 2a, proof-of-concept study wa
Autor:
Khashayar Vahdat, Anita Scribner, Tiffany Egbe, Olubadewa Fatunde, Shahab Akvan, Prashanth Peddi
Publikováno v:
Journal of the American College of Cardiology. 75:3421